These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35182297)

  • 1. Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy.
    Yuan F; Wang Y; Ma C
    Curr Treat Options Oncol; 2022 Feb; 23(2):188-198. PubMed ID: 35182297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The 2021 WHO classification of tumours of the central nervous system].
    Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
    Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
    Oztek MA; Noda SM; Romberg EK; Cole BL; Wright JN; Ishak GE; Perez FA
    Pediatr Radiol; 2023 Mar; 53(3):523-543. PubMed ID: 36348014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology and clinical implications of diffuse glioma.
    Chai R; Fang S; Pang B; Liu Y; Wang Y; Zhang W; Jiang T
    Chin Med J (Engl); 2022 Dec; 135(24):2914-2925. PubMed ID: 36728558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for glioma: Current management and future application.
    Xu S; Tang L; Li X; Fan F; Liu Z
    Cancer Lett; 2020 Apr; 476():1-12. PubMed ID: 32044356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
    Gestrich CK; Couce ME; Cohen ML
    Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
    Perez A; Huse JT
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.
    Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH
    J Magn Reson Imaging; 2023 Sep; 58(3):677-689. PubMed ID: 37069792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
    Yoda RA; Cimino PJ
    Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification.
    Tran S; Bielle F
    Curr Opin Oncol; 2022 Nov; 34(6):670-675. PubMed ID: 36093875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
    Miller DC
    Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the molecular genetics of gliomas - implications for classification and therapy.
    Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
    Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2021 World Health Organization Classification of Brain Tumors.
    Meredith DM; Pisapia DJ
    Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.
    Bai J; Varghese J; Jain R
    Top Magn Reson Imaging; 2020 Apr; 29(2):71-82. PubMed ID: 32271284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
    Onizuka H; Masui K; Komori T
    Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple approach for the histomolecular diagnosis of central nervous system gliomas based on 2021 World Health Organization Classification.
    Kurdi M; Moshref RH; Katib Y; Faizo E; Najjar AA; Bahakeem B; Bamaga AK
    World J Clin Oncol; 2022 Jul; 13(7):567-576. PubMed ID: 36157161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma.
    Back M; Rodriguez M; Jayamanne D; Khasraw M; Lee A; Wheeler H
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):556-562. PubMed ID: 29980381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.